Bridge Biotherapeutics, Inc.
Bridge Biotherapeutics, Inc.
Explore linked clinical trials.1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| First-in-Human Study of BBT-207 in Advanced Non-Small Cell Lung Cancer Harboring EGFR Mutation After Treatment With EGFR TKI | EGFR Mutant Advanced Non-Small Cell Lung Cancer | Active, not recruiting | Phase 1 / Phase 2 | 2025-04-27 | NCT05920135 |